Answers are grounded in this paper and cite their sources.
Given the past decade's dramatic increase in glucagon-like peptide-1 receptor agonist (GLP-1 RA) use among people with type 2 diabetes, clinicians have raised concerns about whether the drugs, which target reward areas in the brain, could lead to suicidal thoughts.
No takes yet. Share an insight, caveat, or question.
Samantha Anderer (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: